Zydus infringed Takeda's patent, rules US court

Zydus Pharmaceutical USA, a subsidiary of Ahmedabad-based Cadila Healthcare, has lost a patent infringement suit in the US. Recently, a New Jersey district court ruled in favour of Japan’s......

Glenmark, Zydus get US go-ahead for Meloxicam

Domestic pharma companies Glenmark Pharmaceuticals and the Ahmedabad-based Zydus Cadila have received US Food and Drug Administration's approval to market Meloxicam oral tablets 7.5 mg and 15 mg in......

Zydus Cadila to sell Atenolol in US

Cadila Healthcare Ltd has announced that Zydus Cadila has received its very first approval from USFDA to market Atenolol, an anti-hypertensive drug, in the US market. Following this, the group......

Zydus may set up US facility

Zydus Pharmaceuticals (USA) Inc, a wholly owned subsidiary of pharmaceutical major Zydus Cadila Healthcare, may set up a manufacturing facility in the US.Zydus Pharmaceuticals, which was set up in......